SK282336B6 - Prostriedok na nazálnu aplikáciu na napomáhanie znižovania potreby fajčenia tabaku a sprejové zariadenie - Google Patents
Prostriedok na nazálnu aplikáciu na napomáhanie znižovania potreby fajčenia tabaku a sprejové zariadenie Download PDFInfo
- Publication number
- SK282336B6 SK282336B6 SK796-94A SK79694A SK282336B6 SK 282336 B6 SK282336 B6 SK 282336B6 SK 79694 A SK79694 A SK 79694A SK 282336 B6 SK282336 B6 SK 282336B6
- Authority
- SK
- Slovakia
- Prior art keywords
- nicotine
- composition
- smoking
- range
- nasal
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 56
- 230000000391 smoking effect Effects 0.000 title claims abstract description 39
- 239000007921 spray Substances 0.000 title claims abstract description 21
- SNICXCGAKADSCV-UHFFFAOYSA-N nicotine Natural products CN1CCCC1C1=CC=CN=C1 SNICXCGAKADSCV-UHFFFAOYSA-N 0.000 claims abstract description 97
- SNICXCGAKADSCV-JTQLQIEISA-N (-)-Nicotine Chemical compound CN1CCC[C@H]1C1=CC=CN=C1 SNICXCGAKADSCV-JTQLQIEISA-N 0.000 claims abstract description 96
- 229960002715 nicotine Drugs 0.000 claims abstract description 96
- 241000208125 Nicotiana Species 0.000 claims abstract description 26
- 235000002637 Nicotiana tabacum Nutrition 0.000 claims abstract description 26
- 239000003795 chemical substances by application Substances 0.000 claims abstract description 6
- 150000003839 salts Chemical class 0.000 claims abstract description 5
- 239000002904 solvent Substances 0.000 claims abstract description 5
- 239000002245 particle Substances 0.000 claims abstract description 4
- 239000000243 solution Substances 0.000 claims description 18
- 238000009472 formulation Methods 0.000 claims description 8
- 229920002134 Carboxymethyl cellulose Polymers 0.000 claims description 4
- 239000001768 carboxy methyl cellulose Substances 0.000 claims description 4
- 235000010948 carboxy methyl cellulose Nutrition 0.000 claims description 4
- 239000008112 carboxymethyl-cellulose Substances 0.000 claims description 4
- 229920002678 cellulose Polymers 0.000 claims description 4
- 239000002953 phosphate buffered saline Substances 0.000 claims description 4
- 239000001913 cellulose Substances 0.000 claims description 3
- LOKCTEFSRHRXRJ-UHFFFAOYSA-I dipotassium trisodium dihydrogen phosphate hydrogen phosphate dichloride Chemical group P(=O)(O)(O)[O-].[K+].P(=O)(O)([O-])[O-].[Na+].[Na+].[Cl-].[K+].[Cl-].[Na+] LOKCTEFSRHRXRJ-UHFFFAOYSA-I 0.000 claims description 3
- 239000000839 emulsion Substances 0.000 claims description 3
- 239000002304 perfume Substances 0.000 claims description 3
- 239000003755 preservative agent Substances 0.000 claims description 3
- 239000004034 viscosity adjusting agent Substances 0.000 claims description 3
- 239000003963 antioxidant agent Substances 0.000 claims description 2
- 239000000654 additive Substances 0.000 claims 1
- 239000008280 blood Substances 0.000 description 14
- 210000004369 blood Anatomy 0.000 description 14
- 210000001331 nose Anatomy 0.000 description 14
- 230000007794 irritation Effects 0.000 description 9
- 239000000443 aerosol Substances 0.000 description 6
- 238000000034 method Methods 0.000 description 6
- 210000002850 nasal mucosa Anatomy 0.000 description 6
- 230000000694 effects Effects 0.000 description 5
- 239000007922 nasal spray Substances 0.000 description 5
- 229940097496 nasal spray Drugs 0.000 description 5
- 235000015218 chewing gum Nutrition 0.000 description 4
- 239000007923 nasal drop Substances 0.000 description 4
- 229940100662 nasal drops Drugs 0.000 description 4
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 3
- 238000010521 absorption reaction Methods 0.000 description 3
- 210000000214 mouth Anatomy 0.000 description 3
- 239000000779 smoke Substances 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- 238000012360 testing method Methods 0.000 description 3
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- 208000025569 Tobacco Use disease Diseases 0.000 description 2
- 230000002411 adverse Effects 0.000 description 2
- 238000013459 approach Methods 0.000 description 2
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 2
- 230000017531 blood circulation Effects 0.000 description 2
- 239000000872 buffer Substances 0.000 description 2
- 235000010980 cellulose Nutrition 0.000 description 2
- 235000019504 cigarettes Nutrition 0.000 description 2
- 239000007933 dermal patch Substances 0.000 description 2
- 230000009931 harmful effect Effects 0.000 description 2
- 230000000241 respiratory effect Effects 0.000 description 2
- 239000011780 sodium chloride Substances 0.000 description 2
- 239000000829 suppository Substances 0.000 description 2
- 238000002560 therapeutic procedure Methods 0.000 description 2
- NOOLISFMXDJSKH-UTLUCORTSA-N (+)-Neomenthol Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@@H]1O NOOLISFMXDJSKH-UTLUCORTSA-N 0.000 description 1
- RFEJUZJILGIRHQ-OMDKHLBYSA-N (2r,3r)-2,3-dihydroxybutanedioic acid;3-[(2s)-1-methylpyrrolidin-2-yl]pyridine Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O.OC(=O)[C@H](O)[C@@H](O)C(O)=O.CN1CCC[C@H]1C1=CC=CN=C1 RFEJUZJILGIRHQ-OMDKHLBYSA-N 0.000 description 1
- 239000005711 Benzoic acid Substances 0.000 description 1
- UGFAIRIUMAVXCW-UHFFFAOYSA-N Carbon monoxide Chemical compound [O+]#[C-] UGFAIRIUMAVXCW-UHFFFAOYSA-N 0.000 description 1
- NOOLISFMXDJSKH-UHFFFAOYSA-N DL-menthol Natural products CC(C)C1CCC(C)CC1O NOOLISFMXDJSKH-UHFFFAOYSA-N 0.000 description 1
- 206010012335 Dependence Diseases 0.000 description 1
- 239000004166 Lanolin Substances 0.000 description 1
- 240000007472 Leucaena leucocephala Species 0.000 description 1
- 235000010643 Leucaena leucocephala Nutrition 0.000 description 1
- 206010057852 Nicotine dependence Diseases 0.000 description 1
- 239000002202 Polyethylene glycol Substances 0.000 description 1
- 241000220317 Rosa Species 0.000 description 1
- 230000002738 anti-smoking effect Effects 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- 235000010323 ascorbic acid Nutrition 0.000 description 1
- 229960005070 ascorbic acid Drugs 0.000 description 1
- 239000011668 ascorbic acid Substances 0.000 description 1
- 235000013871 bee wax Nutrition 0.000 description 1
- 239000012166 beeswax Substances 0.000 description 1
- 230000006399 behavior Effects 0.000 description 1
- 235000010233 benzoic acid Nutrition 0.000 description 1
- 210000000621 bronchi Anatomy 0.000 description 1
- 239000006172 buffering agent Substances 0.000 description 1
- 230000000711 cancerogenic effect Effects 0.000 description 1
- 229910002091 carbon monoxide Inorganic materials 0.000 description 1
- 231100000315 carcinogenic Toxicity 0.000 description 1
- 239000003638 chemical reducing agent Substances 0.000 description 1
- 230000001055 chewing effect Effects 0.000 description 1
- 229940112822 chewing gum Drugs 0.000 description 1
- 238000002716 delivery method Methods 0.000 description 1
- 230000008021 deposition Effects 0.000 description 1
- 239000006196 drop Substances 0.000 description 1
- 201000006549 dyspepsia Diseases 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 239000012458 free base Substances 0.000 description 1
- 235000019388 lanolin Nutrition 0.000 description 1
- 229940039717 lanolin Drugs 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 229940041616 menthol Drugs 0.000 description 1
- 229920000609 methyl cellulose Polymers 0.000 description 1
- 239000001923 methylcellulose Substances 0.000 description 1
- 235000010981 methylcellulose Nutrition 0.000 description 1
- 230000003278 mimic effect Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 210000004400 mucous membrane Anatomy 0.000 description 1
- 210000003928 nasal cavity Anatomy 0.000 description 1
- 239000008194 pharmaceutical composition Substances 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 230000001766 physiological effect Effects 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 238000012552 review Methods 0.000 description 1
- 206010039083 rhinitis Diseases 0.000 description 1
- 238000005507 spraying Methods 0.000 description 1
- 150000003431 steroids Chemical class 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 230000001052 transient effect Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/465—Nicotine; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0043—Nose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/34—Tobacco-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/36—Opioid-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Addiction (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Psychiatry (AREA)
- Otolaryngology (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Confectionery (AREA)
- Cosmetics (AREA)
- Manufacture Of Tobacco Products (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Plant Substances (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB929200047A GB9200047D0 (en) | 1992-01-03 | 1992-01-03 | Nicotine-containing nasal spray |
| PCT/CA1993/000003 WO1993012764A1 (fr) | 1992-01-03 | 1993-01-04 | Composition et procede de suppleance au tabagisme |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| SK79694A3 SK79694A3 (en) | 1995-06-07 |
| SK282336B6 true SK282336B6 (sk) | 2002-01-07 |
Family
ID=10708064
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SK796-94A SK282336B6 (sk) | 1992-01-03 | 1993-01-04 | Prostriedok na nazálnu aplikáciu na napomáhanie znižovania potreby fajčenia tabaku a sprejové zariadenie |
Country Status (21)
| Country | Link |
|---|---|
| US (1) | US5656255A (fr) |
| EP (1) | EP0619729B1 (fr) |
| JP (1) | JP3830158B2 (fr) |
| KR (2) | KR100317426B1 (fr) |
| AT (1) | ATE182070T1 (fr) |
| AU (1) | AU664415B2 (fr) |
| CA (1) | CA2127253C (fr) |
| CZ (1) | CZ294555B6 (fr) |
| DE (1) | DE69325643T2 (fr) |
| DK (1) | DK0619729T3 (fr) |
| ES (1) | ES2135460T3 (fr) |
| FI (1) | FI111049B (fr) |
| GB (1) | GB9200047D0 (fr) |
| GR (1) | GR3031075T3 (fr) |
| HU (1) | HUT73247A (fr) |
| NO (1) | NO308123B1 (fr) |
| NZ (1) | NZ246533A (fr) |
| RU (1) | RU2118897C1 (fr) |
| SK (1) | SK282336B6 (fr) |
| UA (1) | UA37201C2 (fr) |
| WO (1) | WO1993012764A1 (fr) |
Families Citing this family (57)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9310412D0 (en) * | 1993-05-20 | 1993-07-07 | Danbiosyst Uk | Nasal nicotine system |
| AUPM835394A0 (en) * | 1994-09-23 | 1994-10-13 | King, Michael G. Dr. | Method for controlling or eliminating the need to smoke tobacco, and for treating ailments which may lead to the said need |
| JPH11507810A (ja) * | 1995-06-05 | 1999-07-13 | ヒューマン ジノーム サイエンシーズ，インコーポレイテッド | Ｇタンパク質副甲状腺ホルモンレセプターｈｌｔｄｇ７４ |
| CA2231968A1 (fr) * | 1998-03-11 | 1999-09-11 | Smoke-Stop, A Partnership Consisting Of Art Slutsky | Methode de production d'un medicament a base de nicotine |
| GB9806937D0 (en) | 1998-03-31 | 1998-05-27 | Procter & Gamble | A spray device |
| CA2359813C (fr) * | 2000-10-24 | 2008-04-22 | Richard L. Jones | Vaporisateur de nicotine pour les muqueuses |
| US7766013B2 (en) | 2001-06-05 | 2010-08-03 | Alexza Pharmaceuticals, Inc. | Aerosol generating method and device |
| US7585493B2 (en) | 2001-05-24 | 2009-09-08 | Alexza Pharmaceuticals, Inc. | Thin-film drug delivery article and method of use |
| US7645442B2 (en) | 2001-05-24 | 2010-01-12 | Alexza Pharmaceuticals, Inc. | Rapid-heating drug delivery article and method of use |
| US20070122353A1 (en) | 2001-05-24 | 2007-05-31 | Hale Ron L | Drug condensation aerosols and kits |
| US7090830B2 (en) | 2001-05-24 | 2006-08-15 | Alexza Pharmaceuticals, Inc. | Drug condensation aerosols and kits |
| US7458374B2 (en) | 2002-05-13 | 2008-12-02 | Alexza Pharmaceuticals, Inc. | Method and apparatus for vaporizing a compound |
| SE0102197D0 (sv) * | 2001-06-20 | 2001-06-20 | Pharmacia Ab | New product and use and manufacture thereof |
| SE521512C2 (sv) | 2001-06-25 | 2003-11-11 | Niconovum Ab | Anordning för administrering av en substans till främre delen av en individs munhåla |
| EP1304048B1 (fr) * | 2001-10-22 | 2004-09-22 | Ivo Pera | Composition pour réduire ou arrêter le tabagisme |
| SE0104388D0 (sv) * | 2001-12-27 | 2001-12-27 | Pharmacia Ab | New formulation and use and manufacture thereof |
| US20030159702A1 (en) * | 2002-01-21 | 2003-08-28 | Lindell Katarina E.A. | Formulation and use manufacture thereof |
| US20030171408A1 (en) * | 2002-03-11 | 2003-09-11 | Caplan Jay L. | Therapeutic method of delivering a medicament to avoid irritating effects on membranes of user |
| US7767698B2 (en) | 2002-06-03 | 2010-08-03 | Mcneil Ab | Formulation and use thereof |
| SE0201669D0 (sv) * | 2002-06-03 | 2002-06-03 | Pharmacia Ab | New formulation and use thereof |
| US20040002520A1 (en) * | 2002-07-01 | 2004-01-01 | Soderlund Patrick L. | Composition and method for cessation of Nicotine cravings |
| US20040105818A1 (en) | 2002-11-26 | 2004-06-03 | Alexza Molecular Delivery Corporation | Diuretic aerosols and methods of making and using them |
| US7913688B2 (en) | 2002-11-27 | 2011-03-29 | Alexza Pharmaceuticals, Inc. | Inhalation device for producing a drug aerosol |
| ES2708552T3 (es) * | 2002-12-20 | 2019-04-10 | Niconovum Ab | Método para la preparación de un material particulado que contiene nicotina con una celulosa cristalina (en particular MCC) |
| JP2007516149A (ja) | 2003-05-21 | 2007-06-21 | アレックザ ファーマシューティカルズ， インコーポレイテッド | 基板温度の均一性を制御する方法、および、内蔵式加熱ユニットおよびそれを使用する薬剤供給ユニット |
| RU2266116C1 (ru) * | 2004-03-29 | 2005-12-20 | Глова Елена Анатольевна | Способ лечения табачной зависимости |
| US7540286B2 (en) | 2004-06-03 | 2009-06-02 | Alexza Pharmaceuticals, Inc. | Multiple dose condensation aerosol devices and methods of forming condensation aerosols |
| EP1781360A1 (fr) | 2004-08-12 | 2007-05-09 | Alexza Pharmaceuticals, Inc. | Dispositif de distribution de drogue par aérosol intégrant des conditionnements thermiques actionnés par percussion |
| AU2005284908B2 (en) | 2004-09-13 | 2011-12-08 | Morningside Venture Investments Limited | Biosynchronous transdermal drug delivery |
| US8252321B2 (en) | 2004-09-13 | 2012-08-28 | Chrono Therapeutics, Inc. | Biosynchronous transdermal drug delivery for longevity, anti-aging, fatigue management, obesity, weight loss, weight management, delivery of nutraceuticals, and the treatment of hyperglycemia, alzheimer's disease, sleep disorders, parkinson's disease, aids, epilepsy, attention deficit disorder, nicotine addiction, cancer, headache and pain control, asthma, angina, hypertension, depression, cold, flu and the like |
| US7766018B2 (en) * | 2004-09-30 | 2010-08-03 | Smoke-Break, Inc. | Device and composition for reducing the incidence of tobacco smoking |
| US8322350B2 (en) | 2004-12-30 | 2012-12-04 | Philip Morris Usa Inc. | Aerosol generator |
| US8323683B2 (en) | 2005-05-18 | 2012-12-04 | Mcneil-Ppc, Inc. | Flavoring of drug-containing chewing gums |
| WO2007104573A2 (fr) | 2006-03-16 | 2007-09-20 | Niconovum Ab | Composition améliorée de tabac à priser |
| RU2330689C2 (ru) * | 2006-09-26 | 2008-08-10 | Михаил Матвеевич Самсонов | Способ прекращения курения |
| EP2121088B1 (fr) | 2007-03-09 | 2016-07-13 | Alexza Pharmaceuticals, Inc. | Unité chauffante à utiliser dans un dispositif d'administration de médicament |
| ES2521494T3 (es) * | 2007-04-02 | 2014-11-12 | Parkinson's Institute | Métodos y composiciones para la reducción de los efectos secundarios de tratamientos terapéuticos |
| JP5041555B2 (ja) * | 2007-11-30 | 2012-10-03 | 日本たばこ産業株式会社 | エアロゾル吸引器のためのエアロゾル発生液 |
| EP2233134A1 (fr) | 2009-03-27 | 2010-09-29 | McNeil AB | Dosage intra-buccal multi-portions avec des propriétés organoleptiques |
| WO2011087393A1 (fr) * | 2010-01-18 | 2011-07-21 | Общество С Ограниченной Ответственностью "Вегавольт" | Composition d'origine végétale destinée à l'inhalation de la fumée générée par sa combustion |
| US20110268809A1 (en) | 2010-04-28 | 2011-11-03 | Paul Andrew Brinkley | Nicotine-Containing Pharmaceutical Compositions |
| US20110274628A1 (en) | 2010-05-07 | 2011-11-10 | Borschke August J | Nicotine-containing pharmaceutical compositions |
| EP2729148A4 (fr) | 2011-07-06 | 2015-04-22 | Parkinson S Inst | Compositions et méthodes de traitement de symptômes chez des patients atteints de la maladie de parkinson |
| US20130078307A1 (en) | 2011-09-22 | 2013-03-28 | Niconovum Usa, Inc. | Nicotine-containing pharmaceutical composition |
| US9907748B2 (en) | 2011-10-21 | 2018-03-06 | Niconovum Usa, Inc. | Excipients for nicotine-containing therapeutic compositions |
| WO2016123406A1 (fr) | 2015-01-28 | 2016-08-04 | Chrono Therapeutics Inc. | Procédés et systèmes d'administration de médicament |
| AU2016228779A1 (en) | 2015-03-12 | 2017-09-07 | Chrono Therapeutics Inc. | Craving input and support system |
| US10532046B2 (en) | 2015-12-03 | 2020-01-14 | Niconovum Usa, Inc. | Multi-phase delivery compositions and products incorporating such compositions |
| US20170165252A1 (en) | 2015-12-10 | 2017-06-15 | Niconovum Usa Inc. | Protein-enriched therapeutic composition |
| WO2017149534A1 (fr) * | 2016-02-29 | 2017-09-08 | Nicogen Ltd. | Formulation de nicotine et aérosols |
| CA3049529A1 (fr) | 2017-01-06 | 2018-07-12 | Chrono Therapeutics Inc. | Dispositifs et methodes d'administration transdermique de medicament |
| SE541358C2 (en) | 2017-05-30 | 2019-08-13 | Enorama Pharma Ab | Nicotine-containing chewing gum compositions |
| US12214118B2 (en) | 2018-02-02 | 2025-02-04 | Alexza Pharmaceuticals, Inc. | Electrical condensation aerosol device |
| CA3101966A1 (fr) | 2018-05-29 | 2019-12-05 | Morningside Venture Investments Limited | Procedes et systemes d'administration de medicament |
| EP3807260B1 (fr) | 2018-06-15 | 2024-09-18 | R. J. Reynolds Tobacco Company | Purification de nicotine |
| US12397141B2 (en) | 2018-11-16 | 2025-08-26 | Morningside Venture Investments Limited | Thermally regulated transdermal drug delivery system |
| CZ309558B6 (cs) * | 2021-05-25 | 2023-04-12 | Consumer Brands International s.r.o. | Náplň nikotinového prostředku, zejména nikotinového sáčku a způsob jeho výroby |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB2030862A (en) * | 1978-04-10 | 1980-04-16 | Smith A | A composition for treating drug addiction such as smoking nicotine-containing products |
| DE3241437A1 (de) * | 1982-11-10 | 1984-05-10 | Ferdinand Prof. Dr.med. 6901 Wilhelmsfeld Schmidt | Mittel zum zwecke der raucherentwoehnung und/oder fuer nebenwirkungsfreien nikotingenuss bei suchtrauchern |
| GB2133691B (en) * | 1983-01-21 | 1986-05-21 | Leo Ab | Smoking substitutes for nasal administration |
| GB8301659D0 (en) * | 1983-01-21 | 1983-02-23 | Leo Ab | Smoking substitutes |
| US4953572A (en) * | 1985-04-25 | 1990-09-04 | Rose Jed E | Method and apparatus for aiding in the reduction of incidence of tobacco smoking |
| US4920989A (en) * | 1985-04-25 | 1990-05-01 | Regents Of The University Of California | Method and apparatus for aiding in the reduction of incidence of tobacco smoking |
| US4715387A (en) * | 1985-08-23 | 1987-12-29 | The Regents Of The Univ. Of California | Aerosol for use in the reduction of tobacco smoking |
| SE8601351D0 (sv) * | 1986-03-24 | 1986-03-24 | Nilsson Sven Erik | Styrd administration av fysiologiskt aktiva emnen |
| GB8614805D0 (en) * | 1986-06-18 | 1986-07-23 | British American Tobacco Co | Aerosol device |
-
1992
- 1992-01-03 GB GB929200047A patent/GB9200047D0/en active Pending
-
1993
- 1993-01-04 AT AT93901989T patent/ATE182070T1/de not_active IP Right Cessation
- 1993-01-04 DE DE69325643T patent/DE69325643T2/de not_active Expired - Lifetime
- 1993-01-04 SK SK796-94A patent/SK282336B6/sk unknown
- 1993-01-04 NZ NZ246533A patent/NZ246533A/en not_active IP Right Cessation
- 1993-01-04 DK DK93901989T patent/DK0619729T3/da active
- 1993-01-04 HU HU9402003A patent/HUT73247A/hu unknown
- 1993-01-04 AU AU33403/93A patent/AU664415B2/en not_active Expired
- 1993-01-04 RU RU94040387A patent/RU2118897C1/ru active
- 1993-01-04 CZ CZ19941608A patent/CZ294555B6/cs not_active IP Right Cessation
- 1993-01-04 UA UA94075668A patent/UA37201C2/uk unknown
- 1993-01-04 KR KR940702316A patent/KR100317426B1/ko not_active Expired - Fee Related
- 1993-01-04 JP JP51133293A patent/JP3830158B2/ja not_active Expired - Lifetime
- 1993-01-04 KR KR1019940702316A patent/KR950700055A/ko not_active Withdrawn
- 1993-01-04 WO PCT/CA1993/000003 patent/WO1993012764A1/fr not_active Ceased
- 1993-01-04 ES ES93901989T patent/ES2135460T3/es not_active Expired - Lifetime
- 1993-01-04 EP EP93901989A patent/EP0619729B1/fr not_active Expired - Lifetime
- 1993-01-04 CA CA002127253A patent/CA2127253C/fr not_active Expired - Lifetime
- 1993-01-04 US US08/256,312 patent/US5656255A/en not_active Expired - Lifetime
-
1994
- 1994-07-01 NO NO942502A patent/NO308123B1/no unknown
- 1994-07-01 FI FI943173A patent/FI111049B/fi not_active IP Right Cessation
-
1999
- 1999-08-26 GR GR990402158T patent/GR3031075T3/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| FI111049B (fi) | 2003-05-30 |
| CZ160894A3 (en) | 1995-09-13 |
| UA37201C2 (uk) | 2001-05-15 |
| FI943173L (fi) | 1994-09-01 |
| JPH07504164A (ja) | 1995-05-11 |
| CA2127253A1 (fr) | 1993-07-08 |
| NO308123B1 (no) | 2000-07-31 |
| DE69325643T2 (de) | 2000-02-10 |
| HUT73247A (en) | 1996-07-29 |
| AU664415B2 (en) | 1995-11-16 |
| SK79694A3 (en) | 1995-06-07 |
| KR950700055A (ko) | 1995-01-16 |
| RU94040387A (ru) | 1996-10-20 |
| GR3031075T3 (en) | 1999-12-31 |
| EP0619729B1 (fr) | 1999-07-14 |
| CA2127253C (fr) | 1999-09-21 |
| DE69325643D1 (de) | 1999-08-19 |
| AU3340393A (en) | 1993-07-28 |
| NO942502L (no) | 1994-09-02 |
| EP0619729A1 (fr) | 1994-10-19 |
| NO942502D0 (no) | 1994-07-01 |
| ES2135460T3 (es) | 1999-11-01 |
| RU2118897C1 (ru) | 1998-09-20 |
| US5656255A (en) | 1997-08-12 |
| FI943173A0 (fi) | 1994-07-01 |
| JP3830158B2 (ja) | 2006-10-04 |
| CZ294555B6 (cs) | 2005-02-16 |
| NZ246533A (en) | 1996-04-26 |
| ATE182070T1 (de) | 1999-07-15 |
| HU9402003D0 (en) | 1994-09-28 |
| KR100317426B1 (fr) | 2001-11-30 |
| WO1993012764A1 (fr) | 1993-07-08 |
| DK0619729T3 (da) | 2000-04-17 |
| GB9200047D0 (en) | 1992-02-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SK282336B6 (sk) | Prostriedok na nazálnu aplikáciu na napomáhanie znižovania potreby fajčenia tabaku a sprejové zariadenie | |
| RU2283111C2 (ru) | Забуференная жидкая никотиновая композиция для легочного введения | |
| CA2359813C (fr) | Vaporisateur de nicotine pour les muqueuses | |
| US8642627B2 (en) | Formulation and use thereof | |
| US5169849A (en) | Nasal pharmaceutical compositions | |
| GB2114001A (en) | Nasal pharmaceutical compositions | |
| IE54532B1 (en) | Improvements in or relating to nasal pharmaceutical compositions | |
| DE102020112143B4 (de) | Nicotin - Corona | |
| RU2625766C1 (ru) | Средство для экстренного восстановления голоса при внезапной афонии | |
| WO2023096535A1 (fr) | Moyen pour personnes arrêtant de fumer | |
| Sestini et al. | Protective Effect of Furosemide, Administered Using a Pressurized Metered Dose Inhaler and a Spacer Device, on the Bronchial Obstructive Response to Ultrasonically Nebulized Distilled Water | |
| KR20030055457A (ko) | 금연보조 에어로졸 |